KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Cash from Operations (2016 - 2026)

AbbVie has reported Cash from Operations over the past 14 years, most recently at 5218000000.0 for Q4 2025.

  • Quarterly Cash from Operations fell 25.96% to 5218000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 19030000000.0 through Dec 2025, up 1.19% year-over-year, with the annual reading at 19030000000.0 for FY2025, 1.19% up from the prior year.
  • Cash from Operations was 5218000000.0 for Q4 2025 at AbbVie, down from 7024000000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 7935000000.0 in Q3 2021 and troughed at 1635000000.0 in Q1 2025.
  • The 5-year median for Cash from Operations is 5114000000.0 (2021), against an average of 5419750000.0.
  • Year-over-year, Cash from Operations crashed 64.06% in 2024 and then surged 126.9% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 5075000000.0 in 2021, then soared by 46.36% to 7428000000.0 in 2022, then crashed by 36.01% to 4753000000.0 in 2023, then surged by 48.29% to 7048000000.0 in 2024, then fell by 25.96% to 5218000000.0 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Cash from Operations are 5218000000.0 (Q4 2025), 7024000000.0 (Q3 2025), and 5153000000.0 (Q2 2025).